14.6.2022 | Business Kuopio

Marginum featured as one of rising stars in Kuopio start-up scene

Marginum Ltd, founded in autumn 2020, is developing next-generation technology for the removal of cancerous tumours. The innovation is based on years of scientific research.
 
The smart tissue monitor developed by the company detects cancer cells by utilising fluorescence. 

“The smart tissue monitor is used to improve treatments and reduce reoperations”, says Adjunct Professor and Resident in neurosurgery, Antti-Pekka Elomaa.

“The monitor is attached to the suction tube used by the surgeon to remove cancer cells. Based on intensity of detected fluorescence, the monitor detects cancer cells from surgical waste”, says CEO Samu Lehtonen
 
Initially, the monitor is to be used in the surgical treatment of brain cancer. The device improves the surgeon’s performance because cancer cells can be removed more accurately and damage to healthy tissue is avoided. Healthcare costs will decrease due to lesser need for reoperations.
 
Marginum is set to begin clinical trials with the smart tissue monitor in autumn. 
 
The original full article in Finnish can be read at Business Kuopio.

LATEST NEWS & PRESS

14.6.2022 | Business Kuopio

Marginum featured as one of rising stars in Kuopio start-up scene

Marginum Ltd, founded in autumn 2020, is developing next-generation technology for the removal of cancerous tumours.

27.4.2022 | Finnish Medical Journal

Smart tissue monitor detects cancer tissues from surgical waste

Precision techniques such as Marginum’s aspirate tissue monitoring enable unprecedently efficient identification of cancer tissue and the best possible treatment.

25.4.2022 | Mediuutiset

New tool for brain surgery in development for neurosurgeons

Contemporary techniques in glioma surgery are limited by their complexity, subjectivity and randomness, resulting in reoperations and suboptimal care.

11.4.2022 | Savon Sanomat

Marginum wins start-up competition at Tahko Ski Lift Pitch 2022

Marginum was selected as the winner of Tahko Ski Lift Pitch and awarded with the chance to be featured on the Nasdaq billboard in New York's Times Square.

7.2.2022 | Finnish Venture Capital Association

Smart tissue monitor developing Marginum Ltd raises first venture capital funding from Nostetta Ventures

Finnish start-up Marginum raises first venture capital funding from Nostetta Ventures for the commercialisation of smart tissue monitor.

5.2.2022 | Savon Sanomat

CEO Samu Lehtonen in Savon Sanomat

CEO Lehtonen shared his thoughts on the development of Marginum’s technology and on how the innovation was borne from multidisciplinary research.